PL4566591T3 - Stała farmaceutyczna postać dawkowania zawierająca ezetymib i pitawastatynę - Google Patents

Stała farmaceutyczna postać dawkowania zawierająca ezetymib i pitawastatynę

Info

Publication number
PL4566591T3
PL4566591T3 PL23214816.3T PL23214816T PL4566591T3 PL 4566591 T3 PL4566591 T3 PL 4566591T3 PL 23214816 T PL23214816 T PL 23214816T PL 4566591 T3 PL4566591 T3 PL 4566591T3
Authority
PL
Poland
Prior art keywords
ezetimible
pitavastatin
dosage form
pharmaceutical dosage
solid pharmaceutical
Prior art date
Application number
PL23214816.3T
Other languages
English (en)
Inventor
Grega BAJC
Kristina DEBELJAK SIMONCIC
Maja OMERZU
Ina KOSMAC
Vesna Kroselj
Original Assignee
Krka, D.D., Novo Mesto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka, D.D., Novo Mesto filed Critical Krka, D.D., Novo Mesto
Publication of PL4566591T3 publication Critical patent/PL4566591T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
PL23214816.3T 2023-12-07 2023-12-07 Stała farmaceutyczna postać dawkowania zawierająca ezetymib i pitawastatynę PL4566591T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP23214816.3A EP4566591B1 (en) 2023-12-07 2023-12-07 SOLID PHARMACEUTICAL FORM CONTAINING EZETIMIBE AND PITAVASTATIN

Publications (1)

Publication Number Publication Date
PL4566591T3 true PL4566591T3 (pl) 2026-04-07

Family

ID=89121633

Family Applications (1)

Application Number Title Priority Date Filing Date
PL23214816.3T PL4566591T3 (pl) 2023-12-07 2023-12-07 Stała farmaceutyczna postać dawkowania zawierająca ezetymib i pitawastatynę

Country Status (4)

Country Link
EP (1) EP4566591B1 (pl)
PL (1) PL4566591T3 (pl)
PT (1) PT4566591T (pl)
SI (1) SI4566591T1 (pl)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1336714C (en) 1987-08-20 1995-08-15 Yoshihiro Fujikawa Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US20060046996A1 (en) 2004-08-31 2006-03-02 Kowa Co., Ltd. Method for treating hyperlipidemia
JP6937195B2 (ja) 2017-09-01 2021-09-22 興和株式会社 医薬組成物
JPWO2020178878A1 (pl) 2019-03-01 2020-09-10
JP2021008432A (ja) 2019-07-01 2021-01-28 興和株式会社 医薬組成物
US11833133B2 (en) 2020-08-13 2023-12-05 Orient Pharma Co., Ltd. Solid oral pharmaceutical composition
CN112999178A (zh) 2021-03-01 2021-06-22 乐普制药科技有限公司 一种依折麦布匹伐他汀钙复方双层片剂

Also Published As

Publication number Publication date
SI4566591T1 (sl) 2026-02-27
EP4566591A1 (en) 2025-06-11
PT4566591T (pt) 2026-03-20
EP4566591B1 (en) 2025-12-31

Similar Documents

Publication Publication Date Title
IL284835A (en) Pharmaceutical combination comprising tno155 and ribociclib
EP4146198A4 (en) Novel compositions of matter and pharmaceutical compositions
EP4149460C0 (en) THERAPEUTIC SOLID DOSAGE FORMS
EP4183391A4 (en) PHARMACEUTICAL COMPOSITION AND ITS USE
PL3938047T3 (pl) Zmostkowane tricykliczne związki karbamoilopirydonowe i ich zastosowanie farmaceutyczne
EP4214183A4 (en) PHARMACEUTICAL COMPOSITIONS AND COMBINATIONS COMPRISING ANDROGEN RECEPTOR INHIBITORS AND USES THEREOF
EP4149470A4 (en) Pharmaceutical formulations and uses thereof
EP4397663A4 (en) 6-AMINOPYRAZOLOPYRIMIDINE COMPOUND AND ITS PHARMACEUTICAL USE
EP4146247A4 (en) PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING SECRETOMES
IL291191A (en) Cdk inhibitors and their use as pharmaceuticals
DK3727555T3 (da) Oral delivery of active drug substances
EP4074334A4 (en) PHARMACEUTICAL COMPOSITION AND ITS USE
IL284733A (en) Pharmaceutical delivery compositions and uses thereof
IL311331A (en) Pharmaceutical composition and use thereof
EP4375300A4 (en) PHARMACEUTICAL COMPOSITION AND ITS USE
EP3784214C0 (en) ORAL LIQUID PHARMACEUTICAL DOSAGE FORM
IL282591A (en) Aminopeptidase a inhibitors and pharmaceutical compositions comprising the same
CL2015003561A1 (es) Composición farmacéutica para administración por vía oral para su uso para la prevención y/o el tratamiento de una enfermedad cardiovascular.
IL312874A (en) Pharmaceutical composition and use thereof
EP4321537A4 (en) Pharmaceutical composition and use thereof
EP3893843C0 (en) Pharmaceutical compositions of furosemide and their uses
PL4566591T3 (pl) Stała farmaceutyczna postać dawkowania zawierająca ezetymib i pitawastatynę
EP3965739C0 (en) DOSAGE FORMULATIONS OF OLEYL PHOSPHOCHOLINE TABLETS
EP4384145C0 (en) PHARMACEUTICAL COMPOSITIONS AND ORAL DOSAGE FORMS OF KETAMINE DERIVATIVES
EP4349366A4 (en) PHARMACEUTICAL COMPOSITION